Healio
healthCenter
Many adults with type 2 diabetes, atherosclerotic CVD not prescribed SGLT2s or GLP-1stranslating…
Most adults with type 2 diabetes and established atherosclerotic cardiovascular disease are not prescribed an SGLT2 inhibitor or a GLP-1 receptor agonist, according to data published in the American Journal of Preventive Cardiology.
Keywords#CVD#GLP-1s#SGLT2s#prescribed sglt2#adults